S 494: National Plan for Epilepsy Act

S 494 in plain English: This bill requires the Department of Health and Human Services to create a National Plan for Epilepsy aimed at preventing, diagnosing, treating, and curing epilepsy. It also establishes an advisory council and mandates regular reports to Congress on progress and recommended actions. All requirements under the bill would end on December 31, 2035.

Stated purpose

This bill directs the Department of Health and Human Services to create a national plan, an advisory council, and regular reporting to coordinate federal efforts to prevent, diagnose, treat, and cure epilepsy.

Key points

• Directs HHS to create and carry out a National Plan for Epilepsy covering prevention, diagnosis, treatment, and cure.
• Requires HHS to coordinate epilepsy-related research and services across all federal agencies.
• Establishes an Advisory Council on Epilepsy Research, Care, and Services to oversee federally funded efforts.
• Requires the advisory council to report to HHS and Congress every two years evaluating federal epilepsy efforts.
• All bill requirements expire on December 31, 2035.

Arguments supporters make

• Epilepsy affects millions of Americans, and a coordinated national plan could close gaps between scattered federal programs and lead to better treatments and outcomes.
• Regular reporting requirements would hold the government accountable and ensure Congress stays informed about progress and remaining needs.
• Including patient advocates and caregivers in the process ensures the plan reflects real-world experiences, not just bureaucratic priorities.

Arguments opponents make

• The bill creates new planning bodies and reporting requirements but does not directly fund research or treatment programs, so it may produce reports without meaningful action.
• Adding another advisory council and review process could duplicate work already done by existing federal agencies, wasting time and administrative resources.
• A sunset date of 2035 may not be enough time to achieve lasting change, and without guaranteed follow-through, the plan's recommendations could be ignored after reports are filed.

Tradeoffs

The bill invests in coordination and oversight structures that could improve long-term outcomes for epilepsy patients, but it does not itself allocate research or treatment funding, leaving the gap between planning and real-world impact dependent on future decisions by Congress and HHS.

Current status in Congress: Passed Senate.

NewsClear — neutral news & congressional tracking · Bill of the Week